[Fosfomycin].
Matsumoto
Tetsuya
T
Department of Microbiology, Toho University School of Medicine.
D000818:Animals; D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents / Q000009:adverse effects; D016470:Bacteremia / Q000188:drug therapy; D001419:Bacteria / Q000187:drug effects; D018441:Biofilms / Q000187:drug effects; D005578:Fosfomycin / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000166:cytology; D007674:Kidney Diseases / Q000139:chemically induced / Q000188:drug therapy; D008214:Lymphocytes / Q000276:immunology; D008247:Lysosomes / Q000187:drug effects; D018716:Molecular Mimicry / Q000187:drug effects; D009504:Neutrophils / Q000276:immunology; D011552:Pseudomonas Infections / Q000188:drug therapy
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D005578:Fosfomycin